What is Sofinnova Partners?
Sofinnova Partners operates as a leading European venture capital firm with a specialized focus on life sciences, encompassing both healthcare and sustainability initiatives. Headquartered across Paris, London, and Milan, the firm boasts a diverse international team possessing extensive scientific, medical, and business acumen. Sofinnova Partners distinguishes itself as an active company builder, engaging across the entire spectrum of life sciences investments, from early-stage seed rounds to later-stage growth capital. The firm is committed to partnering with ambitious entrepreneurs, often taking a lead or cornerstone investor role, to foster the development of transformative innovations poised to create a positive impact on the collective future.
How much funding has Sofinnova Partners raised?
Sofinnova Partners has raised a total of $1B across 1 funding round:
Share Placement
$1B
Share Placement (2022): $1B with participation from Apollo Global Management
Key Investors in Sofinnova Partners
Apollo Global Management
Apollo Global Management is a major investment firm, likely providing significant capital for strategic initiatives and growth phases of companies within Sofinnova Partners' portfolio.
What's next for Sofinnova Partners?
The substantial enterprise-level funding and recent strategic investment indicate Sofinnova Partners is well-positioned for continued expansion and deeper engagement in its core life sciences verticals. This capital infusion will likely fuel further company-building activities, enabling the firm to identify and support groundbreaking innovations from seed to later stages. The firm's hands-on approach suggests a strategic focus on nurturing portfolio companies through critical growth phases, aiming to solidify their market leadership and drive impactful advancements in healthcare and sustainability.
See full Sofinnova Partners company page
